NCT05431725: Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent |
|
|
| Completed | 3 | 2202 | RoW | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, Sinovac-QIV, Control Quadrivalent influenza virus vaccine, Vaxigrip Tetra-QIV | Sinovac Biotech Co., Ltd, Pontificia Universidad Catolica de Chile, Sinovac Biotech Co., Ltd | Seasonal Influenza | 07/23 | 07/23 | | |
